av/cymabay-therapeutics--big.svg

NASDAQ:CBAY

CymaBay Therapeutics Inc

  • Stock

USD

Last Close

32.47

21/03 20:00

Market Cap

2.61B

Beta: 0.26

Volume Today

8.35M

Avg: 1.67M

PE Ratio

−23.78

PFCF: −42.19

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-10.07M
-
-31.92M
216.86%
-15.53M
51.35%
-26.67M
71.75%
-27.56M
3.32%
-72.55M
163.27%
-102.81M
41.71%
-50.99M
50.41%
-90.00M
76.52%
-106.00M
17.78%
-105.37M
0.60%
depreciation and amortization
55K
-
18K
67.27%
22K
22.22%
29K
31.82%
35K
20.69%
105K
200%
572K
444.76%
632K
10.49%
688K
8.86%
710K
3.20%
681K
4.08%
deferred income tax
-90K
-
7.69M
8,645.56%
-10.61M
237.95%
50K
100.47%
5.57M
11,048%
1.75M
68.60%
-3.15M
279.83%
637K
-
-2.73M
-
stock based compensation
892K
-
1.29M
44.84%
2.49M
92.49%
2.47M
0.56%
4.92M
98.95%
7.01M
42.54%
10.47M
49.27%
7.32M
30.03%
10.00M
36.48%
9.52M
4.79%
15.23M
60.03%
change in working capital
701K
-
1.60M
128.82%
78K
95.14%
290K
271.79%
-3.04M
1,148.62%
8.86M
391.32%
-3.91M
144.09%
-1.59M
59.27%
6.35M
499.18%
-2.34M
136.83%
5.63M
340.79%
accounts receivables
-2K
-
-101K
4,950%
211K
308.91%
-5M
-
inventory
699K
-
304K
56.51%
938K
208.55%
1.43M
-
accounts payables
40K
-
1.39M
3,370.00%
-1.08M
177.59%
-109K
89.88%
412K
477.98%
662K
60.68%
530K
19.94%
-2.27M
528.68%
2.31M
201.63%
-1.44M
162.54%
2.73M
289.20%
other working capital
-36K
-
13K
136.11%
6K
53.85%
399K
6,550%
120K
69.92%
8.20M
6,730.83%
-4.44M
154.12%
681K
115.35%
4.04M
493.54%
-895K
122.14%
2.90M
424.02%
other non cash items
57K
-
198K
247.37%
228K
15.15%
476K
108.77%
437K
8.19%
-115K
126.32%
910K
891.30%
-104K
111.43%
2.90M
2,883.65%
14.03M
384.73%
14.03M
0.04%
net cash provided by operating activities
-8.46M
-
-21.11M
149.63%
-23.32M
10.47%
-23.35M
0.12%
-19.63M
15.93%
-54.94M
179.83%
-97.91M
78.23%
-44.73M
54.32%
-69.43M
55.24%
-84.08M
21.10%
-72.53M
13.74%
investments in property plant and equipment
-103K
-
-42K
-
-27K
35.71%
-529K
1,859.26%
-315K
40.45%
-21K
93.33%
-87K
314.29%
-148K
70.11%
-445K
200.68%
acquisitions net
-199K
-
-1.95M
877.39%
-2.24M
15.01%
-104K
95.35%
637K
712.50%
-874K
237.21%
-7.86M
799.77%
purchases of investments
-6.93M
-
-27.33M
294.26%
-42.79M
56.54%
-22.91M
46.47%
-98.39M
329.52%
-276.38M
180.92%
-290.89M
5.25%
-176.30M
39.39%
-78.08M
55.71%
-174.98M
124.09%
-305.67M
74.69%
sales maturities of investments
44K
-
10.50M
23,761.36%
31.70M
201.98%
50.08M
57.94%
30.88M
38.33%
222.80M
621.41%
256.86M
15.29%
224.28M
12.69%
126.76M
43.48%
129.14M
1.88%
219.55M
70.01%
other investing activites
658K
-
199K
-
1.95M
877.39%
2.24M
15.01%
104K
95.35%
-637K
712.50%
874K
237.21%
7.86M
799.77%
net cash used for investing activites
-6.23M
-
-16.94M
171.83%
-11.08M
34.57%
27.13M
344.77%
-67.53M
348.92%
-54.11M
19.87%
-34.35M
36.52%
47.96M
239.63%
48.59M
1.32%
-45.98M
194.64%
-86.57M
88.25%
debt repayment
-244K
-
-4.76M
1,849.18%
-986K
79.27%
-3.14M
218.15%
-6.53M
108.07%
-47.74M
-
-25M
47.63%
common stock issued
26.51M
-
25.43M
4.09%
25.38M
0.22%
100.44M
-
135.52M
34.93%
107.75M
20.49%
92K
99.91%
70.50M
76,529.35%
-459K
100.65%
345.77M
75,431.59%
common stock repurchased
-3K
-
-459K
-
dividends paid
-25M
-
other financing activites
4.85M
-
51K
98.95%
9.91M
19,327.45%
2.42M
-
6.00M
147.73%
386K
93.56%
92K
76.17%
95.69M
103,914.13%
75.47M
21.14%
net cash used provided by financing activities
31.36M
-
25.24M
19.54%
30.53M
20.96%
-986K
103.23%
99.72M
10,213.49%
134.99M
35.37%
108.13M
19.90%
92K
99.91%
118.45M
128,655.43%
24.55M
79.27%
345.77M
1,308.44%
effect of forex changes on cash
-428K
-
net change in cash
16.68M
-
-12.81M
176.85%
-3.88M
69.72%
2.79M
171.88%
12.56M
350.30%
25.94M
106.55%
-24.13M
193.00%
3.32M
113.78%
97.61M
2,836.61%
-105.52M
208.10%
186.24M
276.51%
cash at beginning of period
7.73M
-
24.40M
215.83%
11.59M
52.52%
7.71M
33.49%
10.49M
36.19%
23.05M
119.67%
48.99M
112.52%
24.87M
49.24%
28.19M
13.37%
125.81M
346.23%
20.29M
83.87%
cash at end of period
24.40M
-
11.59M
52.52%
7.71M
33.49%
10.49M
36.19%
23.05M
119.67%
48.99M
112.52%
24.87M
49.24%
28.19M
13.37%
125.81M
346.23%
20.29M
83.87%
206.53M
917.87%
operating cash flow
-8.46M
-
-21.11M
149.63%
-23.32M
10.47%
-23.35M
0.12%
-19.63M
15.93%
-54.94M
179.83%
-97.91M
78.23%
-44.73M
54.32%
-69.43M
55.24%
-84.08M
21.10%
-72.53M
13.74%
capital expenditure
-103K
-
-42K
-
-27K
35.71%
-529K
1,859.26%
-315K
40.45%
-21K
93.33%
-87K
314.29%
-148K
70.11%
-445K
200.68%
free cash flow
-8.46M
-
-21.22M
150.85%
-23.32M
9.93%
-23.39M
0.30%
-19.66M
15.97%
-55.47M
182.14%
-98.23M
77.10%
-44.75M
54.45%
-69.52M
55.36%
-84.23M
21.16%
-72.98M
13.36%

All numbers in USD (except ratios and percentages)